Independent budget-control support for biotech, pharma, and medical-device sponsors — across CRO, vendor, site, pass-through, invoice, change-order, and rescue-budget cost exposure.
Study budgets do not collapse overnight. They erode through thousands of small scope assumptions, unmonitored monitoring units, front-loaded milestones, and unchecked change-order claims.
Without active sponsor-side commercial tracking, budget variance remains invisible until the sponsor receives a critical invoice, trial delay, or massive budget overrun.
Vague patient recruitment rates or site-activation timelines in initial bidding result in immediate scope deficits.
Clinical teams agree on a day to day small scope changes that never entered a formal change order; project management and finance get the real total cost out of sight
Change orders arrive when the CRO is fully embedded and timelines are critical, giving sponsors zero negotiation leverage.
Clinical operations, purchasing, finance, and legal stakeholders operate from different frameworks without a shared language.
Sponsor leverage is strongest before contract signature, but it should not vanish once the trial is in full execution. CILIQUE helps biotech, pharma, and medical-device sponsors defend their position in change-order discussions by clarifying what was originally agreed, what has genuinely changed, what is commercially justified, and where costs can be challenged without putting trial delivery at risk.
Sponsors can compare assumptions and drive competition before any contract is signed.
Sponsors must build solid payment schedules and contract safeguards into the MSA/SOW.
Operational urgency rises. Switching costs make it nearly impossible to walk away from the vendor.
Sponsor is under intense schedule pressure, forced to accept inflated claims to prevent trial shutdown.
CRO budget problems sit in the structural gaps between different company functions. Clinical Operations focuses on operational delivery. Finance manages the corporate burn rate. Procurement negotiates vendor pricing terms. Legal safeguards contract language.
But without a unified sponsor-side resource translating clinical trial metrics directly into commercial safeguards, budget drift occurs unchecked.
CILIQUE works in this gap. We review trial budgets, proposals, MSA terms, payment structures, invoice details, and change-order justifications. The result is a commercially firm, evidence-backed position on what should be accepted, challenged, or monitored.
We focus on the four critical stages where trial budgets are defined, negotiated, defended, or recovered.
Know what the trial should cost before you sign. CILIQUE structures RFPs, compares CRO proposals, reviews baseline assumptions, identifies hidden cost drivers, and helps sponsors select vendors that fit the trial parameters.
Review My CRO ProposalBuild budget control into the contract before execution starts. CILIQUE supports negotiation of scope assumptions, service levels, milestones, pass-throughs, and payment triggers to safeguard sponsor leverage.
Strengthen My CRO ContractDetect cost drift early and challenge unsupported claims factually. CILIQUE reconciles monthly invoices against scope and performance, tracks variance, audits change orders, and supports Fair Deal negotiations.
Review My Change OrderAt trial close-out, CILIQUE reconciles paid amounts against performed services, milestone payments, pass-through costs, unused budget items, and under-delivered activities — identifying credits, recoveries, or final negotiation opportunities.
Reconcile My Trial BudgetWe also support site feasibility studies, protocol cost-risk analysis, rescue-trial turnaround strategy, interim outsourcing management, and custom cross-functional team outsourcing training.
A strong CRO relationship is critical to study success. But sponsors should not feel compelled to buy harmony by approving every unexpected budget claim.
CILIQUE’s **Fair Deal** approach separates legitimate, performance-backed work scope from avoidable, unsupported, or poorly documented cost increases.
"Pay what is justified. Challenge what is not. Preserve the relationship where possible. Protect the sponsor’s budget always."
Real-world commercial results delivered across clinical trials. All outcomes are project-specific and qualified.
In a Phase 2 GMO trial outsourcing project, CILIQUE helped identify a mid-sized specialized CRO and validate its ability to deliver the study at the required quality level. This gave the sponsor the evidence needed to choose a more cost-effective CRO option without compromising trial execution.
When a biotech sponsor received an unexpected CRO change request, CILIQUE audited the original contract baseline and SOW assumptions to build an evidence file.
CILIQUE implemented monthly invoice reconciliation and service tracking for a Phase 1 oncology trial, flagging accrual errors during study initiation.
*Results depend on trial scope, CRO contract structure, baseline assumptions, evidence quality, and sponsor negotiation context.
CILIQUE was founded by Leif Kuse, who brings more than 20 years of experience in clinical trial outsourcing, project controlling, budgeting, CRO contract negotiations, and sponsor-side outsourcing leadership.
His background combines business administration, law, operational trial outsourcing, budget control, and vendor-management leadership. This matters because CRO budget issues are rarely just clinical, financial, or legal. They emerge where scope, delivery, contracts, invoices, and operational reality no longer align.
CILIQUE exists to help biotech and pharma sponsors negotiate, challenge, and control CRO-related cost exposure on equal commercial footing with experienced CRO teams.
“We outsourced and completed our most important Phase 3 clinical trial with CILIQUE to a CRO who performed the project to our full satisfaction. CILIQUE helped us to reduce costs and focus the CRO on the crucial activities. We look forward to engaging CILIQUE again for our upcoming projects and can recommend their experience and work product as well as immediate and professional response to any request.”
“When realizing how hidden some costs in CRO proposals are and how difficult or almost impossible it is to arrive at a sufficient level of transparency, we sought the skills developed and applied over decades by CILIQUE. That decision proved to be a very prudent one. We have decided to secure CILIQUE's expertise during the course of the study. That will help us to ensure smooth processing of change order negotiations, vendor management, and proper invoicing by the CRO. Based on our very positive experience, we will certainly work with CILIQUE in any further clinical program.”
“CILIQUE gave us important insight into clinical trial costing and scenario estimation. Their presentation of their analysis was clear and easy to follow. We have now moved forward to working with the CILIQUE team in the RFP process for our upcoming clinical trial.”
“Within the CILIQUE Alliance network, we were able to successfully identify a specialized CRO to conduct our Phase 2 trial. It was pivotal for us to identify a vendor who works with us in a collaborative way on the same eye level. We were very pleased about the robust budgets we received at more competitive pricing due to CILIQUE terms.”
“We have been working with CILIQUE since 2016 and they supported us with CRO selection, change order negotiation and budget controlling. CILIQUE was pivotal for our most important trial to avoid CRO cost overruns and to negotiate and reduce the amount of CRO change orders. That alone saved us a 7-figure amount representing 20% of CRO fees. In addition, their efficient budget controlling successfully helped contain CRO cost increases in a mid-six-figure amount. The investment in the collaboration with CILIQUE paid off immediately and could be directly measured by realized cost savings through discounts and successful negotiations.”
Let us make your clinical trial our next commercial success story. Partner with CILIQUE to secure your trial budget, align your CRO contract, and safeguard your clinical runway.
Schedule My ReviewSponsor-Side Change Order Audit Tool
Download the **CILIQUE Change-Order Review Checklist** — a practical guide for sponsors who need to analyze whether a newly submitted CRO cost expansion is commercially justified, negotiable, or unsupported.
This sponsor-side guide helps you structure a fact-based review:
